398 results on '"Yonker, Lael M."'
Search Results
2. Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
3. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
4. Monocyte Anisocytosis Changes in Patients after Major Burn Injuries
5. Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial
6. Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
7. Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants
8. Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort
9. Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
10. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
11. Response by Yonker et al to Letter Regarding Article, “Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis”
12. COVID-19 mRNA vaccines induce robust levels of IgG but limited amounts of IgA within the oronasopharynx of young children
13. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children
14. Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
15. Pediatric biorepository participation during the COVID-19 pandemic: predictors of enrollment and biospecimen donation
16. Heterogeneity in the evaluation of suspected MIS-C: a cross-sectional vignette-based survey
17. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
18. Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
19. Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
20. BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
21. Carboxylated Nanoparticle Surfaces Enhance Association with Mucoid Pseudomonas aeruginosa Biofilms
22. Depths of Dysfunctional Epithelial and Immune Crosstalk in Cystic Fibrosis Revealed
23. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF
24. Neutrophil dysfunction in cystic fibrosis
25. Genetic Pediatric Pulmonary Disease
26. COVID-19 in Pediatric Populations
27. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses
28. Humoral signatures of protective and pathological SARS-CoV-2 infection in children
29. Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants
30. Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial
31. Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children
32. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women
33. Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
34. The CF-CARES primary palliative care model: A CF-specific structured assessment of symptoms, distress, and coping
35. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children
36. Monocyte anisocytosis corresponds with increasing severity of COVID-19 in children
37. Humoral profiling of pediatric patients with cancer reveals robust immunity following anti‐SARS‐CoV‐2 vaccination superior to natural infection
38. The effect of activity and face masks on exhaled particles in children
39. Aerosol Production by Children Performing Spirometry and Implications During a Pandemic
40. Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children
41. Rapid establishment of a COVID-19 perinatal biorepository: early lessons from the first 100 women enrolled
42. Lung transplant referral practice patterns: a survey of cystic fibrosis physicians and general pulmonologists
43. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier
44. Genetic Pediatric Pulmonary Disease
45. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children
46. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
47. Development of a Cystic Fibrosis Primary Palliative Care Intervention: Qualitative Analysis of Patient and Family Caregiver Preferences
48. sj-docx-2-jpx-10.1177_23743735231161486 - Supplemental material for Development of a Cystic Fibrosis Primary Palliative Care Intervention: Qualitative Analysis of Patient and Family Caregiver Preferences
49. sj-docx-1-jpx-10.1177_23743735231161486 - Supplemental material for Development of a Cystic Fibrosis Primary Palliative Care Intervention: Qualitative Analysis of Patient and Family Caregiver Preferences
50. Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.